Skip to content

Clinical trials

Lung Diseases trials in Portugal

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Country / region: Portugal Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20141
20161
20171
20192
20202
20211
20231
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting6
Completed3
Unknown status2
Enrolling by invitation1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
United Therapeutics2
AIRNA Corporation1
Aveiro University1
Bayer1
Centro Hospitalar Universitario do Algarve1
Eli Lilly and Company1
General Practitioners Research Institute1
Grifols Therapeutics LLC1
Hoffmann-La Roche1
Hospital Sao Joao1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases14
Respiratory Tract Diseases8
Carcinoma, Non-Small-Cell Lung3
Cardiovascular Diseases3
Lung Neoplasms3
Pathologic Processes3
Pulmonary Disease, Chronic Obstructive3
COVID-192
Carcinoma, Bronchogenic2
Connective Tissue Diseases2

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.